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Human holocarboxylase synthetase shows a high degree of sequence homology in the catalytic
domain with bacterial biotin ligases such as Escherichia coli BirA, but differs in the length and
sequence of the N-terminus. Despite several studies having been undertaken on the N-terminal
region of hHCS, the role of this region remains unclear. We determined the structure of the N-ter-
minal domain of hHCS by limited proteolysis and showed that this domain has a crucial effect on the
enzymatic activity. The domain interacts not only with biotin acceptor protein, but also with the cat-
alytic domain of hHCS, as shown by nuclear magnetic resonance (NMR) experiments. We propose
that the N-terminal domain of hHCS recognizes the charged region of biotin acceptor protein, dis-
tinctly from the recognition by the catalytic domain.
Structured summary:
MINT-7543113: hHCS (uniprotkb:P50747) and hHCS (uniprotkb:P50747) bind (MI:0407) by nuclear
magnetic resonance (MI:0077)
MINT-7543096, MINT-7543129: ACC75 (uniprotkb:O00763) and hHCS (uniprotkb:P50747) bind
(MI:0407) by nuclear magnetic resonance (MI:0077)
MINT-7543053: hHCS (uniprotkb:P50747) enzymaticly reacts (MI:0414) ACC75 (uniprotkb:O00763) by
nuclear magnetic resonance (MI:0077)
MINT-7543070: hHCS (uniprotkb:P50747) enzymaticly reacts (MI:0414) ACC75 (uniprotkb:O00763) by
enzymatic study (MI:0415)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction ipates in the binding of biotin to the cognate proteins. For all BPLs,Biotin (vitamin H) is an indispensible cofactor that is synthe-
sized by plants and most prokaryotes and is required by all organ-
isms. In cells, biotin is covalently attached at a speciﬁc lysine
residue in the biotin-dependent enzymes [1]. These enzymes gen-
erally capture CO2 from bicarbonate and catalyze the transfer of
this carboxylate to organic acids to form various cellular metabo-
lites using the biotin cofactor as a mobile carboxyl carrier [2]. Bio-
tin protein ligase (BPL), also referred to as BirA in Escherichia coli
[3] and holocarboxylase synthetase (HCS) in eukaryotes [4], partic-chemical Societies. Published by E
ical shift perturbation; HCS,
le quantum coherence; NMR,
agnetic Resonance Research,
chang-Eup, Cheongwon-Gun,
0 5059.
hjeon@kbsi.re.kr (Y.H. Jeon).the addition of biotin occurs via the following two-step process.
BiotinþMgATP $ Biotinyl-50-AMPþ PPi
Biotinyl-50-AMPþ apocarboxylase ! holocarboxylaseþ AMP
In the ﬁrst step, BPL catalyzes the conversion of biotin to biotinyl-
50-AMP at the expense of ATP. In the second step, the biotinyl group
binds to the apocarboxylase via the speciﬁc lysine e-amino group.
The open reading frame of full-length human HCS encodes a
protein of 726 amino acids with a molecular weight of 81 kDa
[5]. However, the existence of at least three splicing variants has
been conﬁrmed [6]. Human HCS has ﬁve different endogenous
substrates: acetyl-CoA carboxylase 1 and 2 (ACC1 and ACC2), pyru-
vate carboxylase (PC), 3-methylcrotonyl-CoA carboxylase (MCC)
and propionyl-CoA carboxylase (PCC). These enzymes are involved
in various cellular metabolic reactions in gluconeogenesis, lipogen-
esis, amino acid metabolism and energy transduction [7,8]. A deﬁ-
ciency in human HCS results in decreased activity of these
carboxylases and affects various metabolic processes.lsevier B.V. All rights reserved.
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structure of bifunctional microbial and eukaryotic BPLs is com-
posed of three main regions: the N-terminal region, a central re-
gion that is required for the catalytic function and the small C-
terminal region. The catalytic domain of prokaryotic BPL was ﬁrst
characterized using the crystal structure of the E. coli BirA complex
with the product analog, biotinyllysine [9]. Subsequently, the cat-
alytic domains of other species were suggested from sequence
homology with E. coli BirA. This sequence also shows signiﬁcant
homology with sequences in the C-terminal half of eukaryotic
BPLs, suggesting that this region can be identiﬁed as the catalytic
domain. The small C-terminal region of BirA is known to be essen-
tial for the catalytic activity and the interaction with its substrates,
ATP and BCCP [10]. Recently, it has been reported that the small C-
terminal region (669H-718R) of human HCS plays a role in sub-
strate recognition [11].
The N-terminal region of E. coli BirA contains a winged helix-
turn-helix DNA-binding motif [9,12]. This provides BirA with an
additional function as a repressor of transcription initiation at the
biotin biosynthetic operon [3,13], rendering this protein bifunc-
tional. Sudha et al. classiﬁed the prokaryotic BPLs into two groups
according to the N-terminal helix-turn-helix (HTH) domain. Group
I is a monofunctional enzymes that lack the sequences correspond-
ing to the N-terminal DNA-binding domain and Group II is a bifunc-
tional enzymes that have a repressor function in the N-terminal
regulatory domain like E. coli BirA [14]. More recently, Novichkov
et al. combined comparative genomics and experimental tech-
niques to identify the bifunctional enzymes with DNA binding do-
mains [15]. In plant, the N-terminal region of BPL contains a
chloroplast-targeting sequence [16]. The N-terminal region of yeast
BPL is known to be necessary for complete catalytic function [17].
Although residues 448–701 inhumanHCSare homologous to the
catalytic domainof E. coliBirA, the amino acid sequence of theN-ter-
minal region (1M-447S) of human HCS is distinct from that of E. coli
BirA. Evidence for the functional importance of this region comes
from the identiﬁcation of mutations in human HCS responsible for
inherited metabolic disease, multiple carboxylase deﬁciency
(MCD).HCS containing several pointmutations inN-terminal region
has been shown to be ‘‘biotin responsive” in expression experiments
andhas been shown to be defective in biotin binding afﬁnity [18,19].
It has been speculated that the N-terminal region of human HCS
might play roles in gene regulation, protein-protein interaction
and substrate recognition [6,11,18]. However, little is known about
the function of this large additional N-terminal region.
Here, we have identiﬁed the structure of the N-terminal domain
of human HCS (hHCS) using limited proteolysis and demonstrated
that this region can rescue the defect of enzymatic activity that is
caused by the deletion of the N-terminal region. The N-terminal
domain interacts not only with the biotin acceptor protein, but also
with the remainder of hHCS, including the catalytic domain. Fur-
thermore, nuclear magnetic resonance (NMR) binding studies with
the biotinoyl domain of human ACC2 showed that the charged sur-
face of the biotinoyl domain was recognized by the hHCS N-termi-
nal domain. This has yielded structural insights into the role of the
N-terminal domain of hHCS.2. Materials and methods
2.1. Limited proteolysis of full-length hHCS
FL-HCS was processed by incubation with several proteases at a
100:1 (w/w) substrate-to-enzyme ratio for 1 h at 4 C. For the ana-
lytical sample, the digestion was stopped by heating in SDS loading
buffer for 5 min at 95 C. The digestion products were resolved in a
reducing and denaturing 12% polyacrylamide gel.2.2. NMR spectroscopy
The NMR measurements were performed at 20 C on either
0.5 mM 15N-labeled apo-hACC75 or 0.5 mM 15N-labeled holo-
hACC75, both of which contained 50 mM HEPES (pH 7.3),
150 mM NaCl, 1 mM DTT and 10% D2O. For the chemical shift per-
turbation (CSP) experiments, we recorded the NMR spectra at 20 C
using samples that contained 0.25 mM 15N-labeled apo-hACC75
and either 50 lM 160-HCS or 0.25 mM NTD–HCS, using the same
buffer conditions. The combined amide CSP was calculated as
Dd = [(DdN/5)2 + (DdH)2]1/2, where DdN and DdH are the shifts in
the 15N and 1H signals, respectively [20]. The NMR spectra of
NTD–HCS, NTD–HCS with hACC75 and 161-HCS were recorded at
room temperature using the same buffer conditions. We used a
5:1 molar ratio of 15N-labeled NTD–HCS to the non-labeled protein
(hACC75 or 161-HCS). The NMR data were recorded on an Avance
500 spectrometer (Bruker) equipped with a cryogenic probe, and
the data were processed with NMRPipe and analyzed using Sparky
3.114.2.3. Circular dichroism
The circular dichroism spectra were acquired using a J-710
spectropolarimeter (Jasco). The NTD–HCS sample (30 lM) was
measured using a 1 mm path in 20 mM Tris (pH 7.5) and 50 mM
NaCl. Data were acquired using a scan rate of 0.2 nm/s, and the
data from ﬁve scans were averaged. The baseline was corrected
using a spectrum that was taken of the same buffer without pro-
tein. The data were converted to the mean residue ellipticities [h]
in deg cm2/dmol using the equation = (hobs/10lc)/r, where hobs is
the ellipticity measured in millidegree, l is the optical path length
(cm), c is the concentration of protein (M) and r is the number of
residues. The composition of the secondary structure elements of
the protein was deconvoluted from the CD spectrum (195–
260 nm) using the neural network-based software CDNN (version
2.1) [21].2.4. In vitro biotinylation assay
The biotinylation of hACC75 was detected quantitatively using
avidin blots. The reactions, containing 80 lM apo-hACC75,
50 mM Tris–HCl (pH 8.0), 3 mM ATP, 5.5 mM MgCl2, 1 mM DTT
and 500 lM biotin, were carried out at 30 C. The reaction was ini-
tiated by the addition of puriﬁed full-HCS or 161-HCS to a ﬁnal
concentration of 15 nM. When the mixture of 161-HCS and NTD–
HCS was used for biotinylation, the mixture was incubated at
4 C overnight. Samples of the reaction mixture were taken at con-
stant time intervals and resolved using an 18% polyacrylamide gel,
before being transferred to a PVDF membrane. The non-speciﬁc
sites on the membrane were blocked using 1% BSA and then incu-
bated with streptavidin-HRP (1:1000) for 1 h at room temperature.
The membrane was developed using AEC/H2O2. The biotinylated
proteins were analyzed using ChemiDoc XRS (Bio-Rad) and Quan-
tity One software.3. Results and discussion
3.1. Structural characterization of the N-terminal region of hHCS
Puriﬁed intact hHCS was subjected to limited proteolysis with
several proteases to deﬁne the structural boundaries of the N-ter-
minal domain within the enzyme. The protein was treated with
subtilisin, proteinase K and chymotrypsin, and the products were
analyzed using SDS–PAGE (Supplementary Fig. S1A). All three pro-
C.-K. Lee et al. / FEBS Letters 584 (2010) 675–680 677teases generated a fragment of about 65 kDa, which contained the
C terminus, as identiﬁed by Western blotting against the His-tag
antibody (data not shown). N-terminal sequencing of these prod-
ucts revealed that the cleavage occurred between 126E and 127N
for subtilisin, between 127N and 128I for proteinase K, and be-
tween 100H and 101L for chymotrypsin (Supplementary
Fig. S1B). This result indicates that the protein contains a prote-
ase-sensitive region between residues 100 and 130.
Polyak et al. [17] have demonstrated the sensitivity of the en-
zyme to protease cleavage using yeast BPL, and they identiﬁed a
protease sensitive site between Lys 240–Asn 260 in yeast BPL. A
ﬂexible region, located between residues 240–260, divides yeast
BPL into a 27 kDa N-terminal domain and a 50 kDa C-terminal do-
main. Similarly, our limited proteolysis study of puriﬁed
full-length hHCS has provided information that has identiﬁed an
N-terminal domain similar to that of yeast BPL. In addition, based
on analyses of the secondary structure (http://bioinf.cs.ucl.ac.uk/
psipred and http://ffas.burnham.org/XtalPred), the residues from
130 to 160 are predicted to form a random structure, whereas
the residues from 160 to the C-terminus are predicted to form a
folded structure. Together with the limited proteolysis results,
the secondary structure prediction suggests that the N-terminal
residues (1–160) form a domain that is independent from the
remaining part of human HCS. Therefore, in this study, we de-
signed an N-terminally truncated HCS starting at Ala 161 (161-
HCS) and we assigned the N-terminal domain as the fragment from
Met 1 to Lys 160 (NTD–HCS).
To characterize the structure of the N-terminal domain of hHCS,
we expressed and puriﬁed the N-terminal 160 residues (NTD–HCS)
in an E. coli system. The amide protons in the heteronuclear singleFig. 1. Activity monitoring using NMR. (A) Overlay of the 2D 15N–1H HSQC spectra for 15N
shown in black and red, respectively. Chemical shift changes were observed for residue
Overlay of the 2D 15N–1H HSQC spectra before and 5 hours after biotinylation using FL-H
and 12 hours after biotinylation using 161-HCS. The black cross peak represents the p
represents the protein after biotinylation.quantum coherence (HSQC) spectrum of 15N-labeled NTD–HCS ap-
peared in the region from 8.0–8.5 ppm, and this is characteristic of
a random coiled structure (Supplementary Fig. S2). The CD spec-
trum showed a strong negative peak below 200 nm, which is char-
acteristic of a random coil conﬁguration, and a negative peak
around 222 nm, suggesting some content of a-helicity (Supple-
mentary Fig. S3). Using the CDNN program [21], we estimated
the secondary structure of the NTD–HCS to be mainly random coil,
with some a-helical structure, consistent with the result of second-
ary structure prediction mentioned above. NTD–HCS has a large
number of charged residues (Lys, Arg, Glu, and Asp) and there
are 12 proline residues that are distributed randomly in the se-
quence. Thus, we assume the N-terminal domain to have mainly
a random coil structure with some a-helical content.
3.2. The activity of full-length and N-terminally truncated hHCS
When the apo-biotinoyl domain is biotinylated to form the
holo-protein, the chemical shifts of the residues that are located
near Lys 929 are changed signiﬁcantly (Fig. 1A). To compare with
the activity of hHCS, we analyzed the biotinylation of the human
ACC2 biotinoyl domain (hACC75) by NMR in the presence of either
full-length hHCS (FL-HCS) or N-terminally truncated hHCS (161-
HCS) containing the catalytic domain. After 5 h reaction with FL-
HCS, the 1H–15N HSQC spectrum of hACC75 showed full conversion
of the biotinoyl domain to its holo-form (Fig. 1B). However, using
161-HCS, the signals from apo-hACC75 still showed substantial
intensities (Fig. 1C), indicating that the enzymatic activity of
161-HCS was decreased signiﬁcantly by the N-terminal truncation.
Even after 12 h, although the intensities were greatly reduced, the-labeled apo- and holo-hACC75. The cross peaks for the apo- and holo-proteins are
s near Lys 929. The blue boxed region is magniﬁed and shown in (B), (C) and (D).
CS (B) and 161-HCS (C) at 30 C. (D) Overlay of the 2D 15N–1H HSQC spectra before
rotein before biotinylation, when only the apo-protein exists. The red cross peak
Fig. 2. Avidin blots of holo-hACC75 at 30 C. The bands show the amount of
biotinylated protein sampled at various time increments following the addition of
HCS. Lane 1, before biotinylation (no ligase added); lanes 2–4 correspond to 1, 3 and
6 h after the addition of ligase; lane 5, identical amounts of holo-protein used as a
control (completely biotinylated hACC75). Biotinylation using FL-HCS, 161-HCS and
NTD–HCS are shown in (A), (B) and (C), respectively. The enzyme mixtures, at 1:1
and 1:2 molar ratios of 161-HCS to NTD, were also used for biotinylation and are
shown in (D) and (E), respectively.
Fig. 3. Chemical shift perturbation in the NTD–HCS system. (A) The 2D 15N–1H HSQC spe
spectra for the 15N-labeled NTD–HCS before and after the addition of 161-HCS. Black repr
(C) Overlay of the 15N–1H HSQC spectra for 15N-labeled NTD–HCS before and after ad
presence of hACC75. (D) The magniﬁed region of the peaks that are numbered in (C). Con
and 1:1 of NTD–HCS to hACC75 are shown in red and blue, respectively. Each color bar
678 C.-K. Lee et al. / FEBS Letters 584 (2010) 675–680peaks corresponding to apo-hACC75 remained, showing that the
NMR signals from the apo-protein coexisted with those of the
holo-protein (Fig. 1D). These results indicate that the enzymatic
activity of 161-HCS was signiﬁcantly reduced by the truncation
of the 160 N-terminal residues.
When the biotinylation reactions were monitored using avidin
blots, similar reaction rates were observed. hACC75 was biotinyla-
ted by FL-HCS, yielding saturation bands on an avidin blot between
3 and 6 h (Fig. 2A). However, when 161-HCS was used in the bio-
tinylation reaction, the band corresponding to the biotinylated
contents did not reach saturation at 6 h after the start of the reac-
tion. This result also indicates that removal of the N-terminal do-
main reduces hHCS activity signiﬁcantly.
Similar to our ﬁndings, N-terminally truncated BPL in yeast
showed a 3500-fold reduction in activity [17], and the authors pro-
posed that the presence of the N-terminal domain is necessary to
produce a functional enzyme. They assumed that in the absence
of the N-terminal domain, the conformational changes that are
associated with substrate binding and are necessary for enzymatic
activity may occur at a slower rate than in the presence of the N-
terminal domain. Therefore, the overall activity of the protein will
be affected [17]. Furthermore, although a shorter deletion of 79
amino acids results in a fully active hHCS, the enzymes that began
at Leu 165 or Leu 166 did not show any activity in the in vitro assay
[18]. Our ﬁndings that the absence of the N-terminal domain
causes a signiﬁcant defect in the activity of hHCS are consistent
with these results.
3.3. The effect of NTD–HCS on the biotinylation activity
As mentioned above, the N-terminally truncated version of
hHCS has defective activity. To investigate the potential role of
NTD–HCS on enzyme activity, we carried out the biotinylation
using 161-HCS in the presence of NTD–HCS. The avidin blotting
for the biotinylation reaction using puriﬁed NTD–HCS did not show
any bands, implying that, as expected, it is unable to biotinylate
the biotin acceptor domain of human ACC2, hACC75 (Fig. 2C). To
our surprise, however, the addition of NTD–HCS to the reactionctrum of NTD–HCS (pH 7.3, Temp = 25 C, 10% D2O). (B) Overlay of the 15N–1H HSQC
esents NTD–HCS and magenta represents the NTD–HCS in the presence of 161-HCS.
dition of hACC75. Black represents NTD–HCS and red represents NTD–HCS in the
trol NTD–HCS is shown in black, and the spectra obtained using molar ratios of 5:1
indicates the respective range of the chemical shift change.
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tinylation activity in vitro, as does full-length hHCS (Fig. 2D and
E). This result indicates that the NTD–HCS has a critical functional
role that can rescue the N-terminal truncation of hHCS with re-
spect to the catalytic reaction with 161-HCS.
Several studies of human HCS have proposed that the N-termi-
nal domain contributes to biotinylation and that it may affect
acceptor substrate recognition. Previously, it was shown that vari-
ous N-terminal deletion constructs of HCS that were prepared by
expression of exonuclease digestion products of the gene had dif-
ferent abilities to biotinylate substrates (the biotinoyl domain of
propionyl-CoA carboxylase and E. coli BCCP). This implied that
disruption of the N-terminal domain interferes with the biotin
transfer reaction [18]. Furthermore, yeast-two-hybrid (Y2H) assays
suggested that this N-terminal region (1M-446F) may be involved
in substrate recognition [11]. More recently, Ingaramo and Beckett
demonstrated that the N-terminus (1M-57G) affects the kinetics
[5]. Based on our results, and considering that the NTD–HCS can
rescue the catalytic function of the N-terminal truncation (even
though it is not attached to the main body of the enzyme), it is
clear that NTD–HCS plays a cooperative role in the catalytic func-
tion with the catalytic domain. We suggested that there is a func-Fig. 4. The analysis of the chemical shift changes of hACC75. (A) The plot represents the
presence and absence of 160-HCS. (B) The CSP differences between apo-hACC75 in the pr
colored according to the chemical shift change induced following the addition of 161-Htional interaction with either the biotin acceptor protein or the
catalytic domain.
3.4. The interaction of NTD–HCS with the substrate and the core
domain of hHCS
To investigate the interaction of NTD–HCS with the remaining
part of hHCS and/or the substrate biotinoyl domain, we performed
NMR CSPs experiments in the presence of 161-HCS or hACC75. The
addition of 161-HCS (including the catalytic domain) to NTD–HCS
induced weak chemical shift changes in the 1H–15N HSQC spectra,
and several signals were broadened (Fig. 3B). This result indicates
that NTD–HCS interacts directly with 161-HCS with weak afﬁnity.
CSPs were also observed when titrating hACC75 with NTD–HCS
(Fig. 3C). These results indicated that NTD–HCS can interact di-
rectly with both 161-HCS and hACC75. The chemical shift changes
of representative signals are shown in the enlarged spectra that
are shown in Fig. 3D, indicating the concentration dependency of
hACC75. Interestingly, when hACC75 was added to the N-terminal
domain, many cross peaks became more intense rather than
broadened (Fig. 3C). This result implies that the chemical ex-
change rate of NTD–HCS in solution was affected by the titrationcombined amide CSP differences between the HSQC spectra of apo hACC75 in the
esence and absence of NTD–HCS. (C) and (D) are surface representations of hACC75,
CS (C) and NTD–HCS (D).
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intensities of the NMR signals (possibly due to faster or slower
conformational exchange). We suggested that when NTD–HCS
binds to the substrate, some conformational change in NTD–HCS
occurs.
3.5. Recognition of the hACC75-binding surface by NTD–HCS
To understand how NTD–HCS interacts with the biotin acceptor
protein (hACC75), we conducted CSP experiments, comparing
NTD–HCS and the N-terminally truncated enzyme (161-HCS). We
analyzed changes in the binding site of hACC75 that occurred on
the addition of NTD–HCS and 161-HCS. Fig. 4 presents the CSPs to-
gether with the residue number and the mapping of the binding
surfaces of hACC75 in each experiment. The residues on the surface
of hACC75 that were perturbed due to the addition of 161-HCS
were essentially the same as those that were perturbed by the
addition of FL-HCS (data not shown). The results indicate the key
residues that are involved in the binding, including the MKMmotif
and glutamic acid residues. However, the addition of NTD–HCS in-
duced the perturbation of NMR signals that are associated with
charged residues on the surface of hACC75, and this is distinct from
the result with 161-HCS. It is notable that NTD–HCS can interact
with the different surfaces of hACC75 and 161-HCS, suggesting a
cooperative interaction with 161-HCS. Together with the result
that indicates the recovery of the biotinylation activity from the
N-terminal truncation by the addition of NTD–HCS, this result im-
plies that NTD–HCS may recruit the substrate to facilitate the bio-
tinylation reaction.
In conclusion, we have determined the structure of the N-termi-
nal domain of hHCS by limited proteolysis and demonstrated that
this region interacts with both the core body of hHCS that contains
the catalytic domain and the biotin acceptor. Furthermore, the CSP
experiments suggest that the charge-charge interaction contrib-
utes to the recognition of the biotin acceptor protein by the N-ter-
minal domain of hHCS. These results may provide structural
insights into the substrate recognition by the N-terminal region
of hHCS.
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